| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a693232b92910547c898db10feb83fef |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
| filingDate |
2018-12-19^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfa9dda2b25962602a9edfacf38c23b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7a51e422ad05e59654b2a2c2f440ffb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fd8e570f290dd1e4643c901af9d1c40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79fe9908630d2743bc5ab6a22248e25d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99f870a5a1a0fb54eea494c75941cd87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ff85d84145fdf6fe482c3d093b9728d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b94e45bd9719709109a08fabc2123e5d |
| publicationDate |
2020-10-28^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3728250-A1 |
| titleOfInvention |
PYRAZOLO[3,4-beta]PYRIDINES AND IMIDAZO[1,5-beta]PYRIDAZINES AS PDE1 INHIBITORS |
| abstract |
The present invention provides compounds of formula (I) that are PDEl enzyme inhibitors and their use as a medicament, in particular for the treatment of neurodegenerative disorders and psychiatric disorders. The present invention also provides pharmaceutical compositions comprising compounds of the invention and methods of treating disorders using the compounds of the invention. |
| priorityDate |
2017-12-20^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |